NASDAQ · LFST
LifeStance Health Group, Inc.
$13.64+$0.25 (+1.83%)
LifeStance Health Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
Loading market information…
NYSE · MD · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pediatrix Medical Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.48% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Pediatrix Medical Group, Inc.’s next earnings report is currently expected on Feb 18, 2027, with estimated earnings per share of $0.60. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pediatrix Medical Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Aug 5, 2025 | $0.53+26.19% vs estimate | $468.84M-1.02% vs estimate |
|---|
| Q1 2025 | May 6, 2025 | $0.33+32.0% vs estimate | $458.36M-0.3% vs estimate |
|---|
| Q4 2024 | Feb 20, 2025 | $0.51+37.84% vs estimate | $502.36M+6.15% vs estimate |
|---|
THE ANALYST VIEW
33 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 5 contributors · Median target $28.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$13.64+$0.25 (+1.83%)
LifeStance Health Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.11% below the high.
$13.81+$0.03 (+0.22%)
Organon & Co.’s quoted price sits in the upper half of its reported 52-week range, 0.14% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$29.46-$0.05 (-0.17%)
Acadia Healthcare Company, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.78% below the high.
$40.45+$0.12 (+0.3%)
Guardian Pharmacy Services, Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.3% below the high.
$124.34+$2.16 (+1.77%)
Addus HomeCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
$16.51-$0.02 (-0.09%)
Select Medical Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 2.83% below the high.
